NZM2:ETR
Novozymes A/S
€58.00
0.00%
(0.00) 1D
Oct 9, 5:35:30 PM GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for NZM2...
Open
€57.64
High
€58.10
Low
€57.64
Mkt. cap
177.38B
Avg. vol.
120.00
Volume
5.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
Open
€57.64
High
€58.10
Low
€57.64
Mkt. cap
177.38B
Avg. vol.
120.00
Volume
5.00
52-wk high
€61.96
52-wk low
€46.74
No. of employees
11K
News stories
From web sources and news partners
www.marketscreener.com
·
33 minutes ago
Nasdaq short interest up about 3% in late September
FOREX.com
·
1 day ago
S&P500 Forecast: SPX falls from record highs ahead of Fed minutes
ChartMill
·
3 hours ago
Friday's session: top gainers and losers in the dow jones index
Profile
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, Greater Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
About Novozymes A/S